Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...
Zenas’ lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and Fc?RIIb, which are broadly present across B cell lineage, to inhibit the activity of ...
China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 24 January ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its ...
Anti-SS-A and anti-SS-B are autoantibodies (antibodies that mistakenly attack the body's own tissue). Elevated levels of these autoantibodies are strongly associated with Sjögren’s disease, in which ...
However, applying this approach to antibodies has proven more challenging, primarily due to the high degree of variability inherent in these proteins. To overcome that limitation, MIT researchers have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback